SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
NPSP NPS Pharmaceutical
An SI Board Since August 1996
Posts SubjectMarks Bans Symbol
363 40 0 NPSP
Emcee:  Jim Langdon Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
238And it's good that the lawsuit has gone away, with NPS getting access to alltuck-8/9/2004
237>>SALT LAKE CITY, Aug 9 /PRNewswire-FirstCall/ -- NPS Pharmaceuticals, Inctuck-8/9/2004
236>>THOUSAND OAKS, Calif.--(BUSINESS WIRE)--July 29, 2004--Amgen Inc. (Nasdatuck-7/30/2004
235SSB: NPS Pharmaceuticals (NPSP, Buy, Speculative) Reporting date: Monday, Augumopgcw-7/9/2004
234Thanks for the GS updates on a number of companies of interest to me. In this ctuck-6/14/2004
233GS Conference: NPSP (IL/N)- FDA filing of Preos by year-end NPSP indicated that mopgcw-6/14/2004
232Thanks to those who were aware of Wyeth's bazedoxifene for not laughing whentuck-6/5/2004
231GS: NPSP (IL/N): Q1, 16c better. Preos dispute should not affect market potentiamopgcw-5/10/2004
230NPS beats estimates due to receipt of milestones, which apparently no analyst gutuck-5/6/2004
229NPS reports after the bell today, with CC at 5PM. >>SALT LAKE CITY, Apriltuck-5/6/2004
228I've got to say that I like this commercialization team better than the Eurotuck-4/29/2004
227GS Analyst Comment Stock rating: In-Line Coverage view: Neutral Small-Cap Growtmopgcw-4/21/2004
226The next conference call Q&A ought to be pretty interesting, eh? All I can tuck-4/21/2004
225they hook up with the guys who distribute CALCI-CHEW??? I may be out of line hermopgcw-4/21/2004
224Wondering how many Nycomed reps will be pushing PREOS. I'm a bit disappointtuck-4/21/2004
223>>SALT LAKE CITY, and ROSKILDE, Denmark, April 21 /PRNewswire-FirstCall/ -tuck-4/21/2004
222NPS Pharmaceuticals Begins Pivotal Study With Teduglutide in Patients With Shortmopgcw-4/6/2004
221The GS Biotechnology teams will host a conference call Thursday, April 1, at 10 mopgcw-4/1/2004
220GS: NPSP (IL/N): Preos reduces fractures in osteoporosis 52-Week Range US$36-15mopgcw-3/30/2004
219Thanks for the notes and congrats on the trade.mopgcw-3/30/2004
218Nice job tuck, Thanks & Congrats. Best of Luck, SSSnowShredder-3/30/2004
217Raw CC notes; answers paraphrased, don't quote me quoting management or Dr. tuck-3/30/2004
216I was about to post that myself. The results seem about as expected. I note thtuck-3/30/2004
215NPS Announces Positive Phase III Study Results for PREOS(R) in Women With Osteopscaram(o)uche-3/30/2004
214GS snip: NPS Pharmaceuticals, Inc. EPS (FY Dec) 2004E ($4.15), 2005E ($3.45) Inmopgcw-3/29/2004
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News